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Abstract 21 
Objective: To examine the association between postpartum depression and child growth in a 22 
Tanzanian birth cohort. 23 
Design: Prospective cohort study. 24 
Setting: Moshi, Tanzania. 25 
Population: Pregnant women over the age of 18 who sought antenatal care at two health clinics 26 
in Moshi, and the children they were pregnant with, were assessed for inclusion in this study.  27 
Methods: The women were interviewed twice during pregnancy and three times after birth, the 28 
final follow-up taking place 2-3 years postpartum. Signs of postpartum depression were assessed 29 
approximately 40 days postpartum with the Edinburgh Postnatal Depression Scale (EPDS). 30 
Main outcome measures: Child growth was assessed with anthropometric measurements at 2-3 31 
years of age, and expressed as mean z-scores. 32 
Results: 1128 mother-child pairs were followed throughout the duration of the study. 12.2% of 33 
the mothers showed signs of postpartum depression. Adjusted mean height-for-age z-score (HAZ) 34 
was significantly lower at 2-3 years follow-up for children of mothers with postpartum depression, 35 
compared to children of mothers without (difference in HAZ: -0.32, 95%CI:-0.49;-0.15). Adjusted 36 
mean weight-for-height z-score (WHZ) was significantly increased for the children exposed to 37 
postpartum depression (difference in WHZ: 0.21, 95%CI:0.02;0.40), while there was no significant 38 
difference in adjusted weight-for-age z-score (WAZ) (difference in WAZ: -0.04, 95%CI:-0.20;0.12). 39 
Conclusions: We found that postpartum depressive symptoms predicted decreased linear height 40 
in children at 2-3 years of age, and slightly increased weight-for-height.  41 
Funding: The Ministry for Foreign Affairs of Denmark (12-006KU), the A.P. Møller foundation 42 
(29190909), and the Lundbeck foundation (F-61171-19-27). 43 
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 45 
Tweetable abstract: Postpartum depression in Tanzanian mothers is associated with impaired 46 
child growth at 2-3 years of age. 47 
 48 
Introduction 49 
Postpartum depression (PPD) is a common and debilitating condition among mothers worldwide. 50 
Studies in sub-Saharan Africa have shown incidence of PPD to be 13-35% (1, 2). Estimates do 51 
however vary greatly depending on country and cultural context, and generally seem to be 52 
increasing(3). According to International Classification of Diseases (ICD-10) PPD is a depression 53 
commencing within six weeks of delivery(4), and involves symptoms such as depressed mood, lack 54 
of interest in surroundings, lack of energy, insomnia and low self-esteem(5).  55 
While PPD clearly has an influence on maternal health, it is also recognized that child mental and 56 
physical development could be detrimentally affected by maternal PPD(3). Maternal depression is 57 
connected to early interaction problems between mother and child and inadequate caregiving, 58 
such as non-exclusive or early cessation of breastfeeding, decreased preventative healthcare 59 
seeking behaviour and undesirable sleep patterns(1, 3, 5-7). Children of depressed mothers are more 60 
likely to get diarrhoea and other childhood infections, and are exposed to more stressors such as 61 
family conflicts, both of which have been shown to influence child growth(5-7).  62 
These shortcomings in parental care ability are particularly likely to impact physical child health in 63 
low income countries (LICs), due to harsher conditions, including food insecurity and sanitation 64 
issues; especially during the postpartum period, where the infant is completely dependent on 65 
their main caregiver, often the mother(5).  66 
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Considering these possible pathways, it seems reasonable that depressive symptoms in the 67 
postpartum period could impair physical child health and growth, particularly in LICs.  68 
Previous research generally supports this hypothesis, but there is a call for more longitudinal 69 
studies in order to investigate causality and pathways(1, 5, 8). Most of the current research for LICs is 70 
from Asia, and there is a definite information gap for sub-Saharan Africa. 71 
The aim of this study is to examine the association between PPD and child growth in a Tanzanian 72 
birth cohort. 73 
 74 
Methods 75 
This prospective cohort study took place in Moshi, in the Kilimanjaro region of northern Tanzania, 76 
and ran from the 1st of March 2014 to 30th of June 2017.  77 
Population 78 
Pregnant women attending antenatal care at either of two primary care facilities were assessed 79 
for eligibility. The primary care facilities Majengo and Pasua were chosen, due to their high 80 
attendance rate of pregnant women.  81 
All consenting pregnant women who sought antenatal care in the aforementioned facilities during 82 
the enrolment period, who were aged 18 or above at the time, and whose gestational age was 83 
below 30 weeks, were eligible for inclusion. Women with multiple or molar pregnancies, or who 84 
planned to give birth outside of Moshi, were excluded. Likewise, mother-child pairs were excluded 85 
if either party died prior to conclusion of the study, or if core information, such as the child’s sex 86 
or age, or mother’s exposure to PPD, was missing from the data set. Comprehensive contact 87 
information was gathered for the participants, and they were reminded of their appointments 88 
beforehand, by phone call and home visit, to minimize loss to follow-up. All participants received 89 
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compensation for their travel expenses. Participants who moved away during the study were 90 
encouraged to come back for follow-up appointments, e.g. when visiting Moshi for family events. 91 
Measures 92 
Included mothers were interviewed five times during the study. The first interview took place at 93 
enrolment, and the next at 34 weeks gestational age, then 48 hours post-delivery, 40 days post-94 
delivery, and 2-3 years post-delivery. Gestational age was determined with ultrasound 95 
examination at enrolment by a trained nurse. Sociodemographic and reproductive health 96 
information was collected at enrolment. Details on exposure to intimate partner violence (IPV) 97 
and HIV status were collected at the second interview. The questions relating to IPV were adopted 98 
directly from the Swahili version of the “WHO Multi-Country Study on Women and Domestic 99 
Violence against Women” as used in the Tanzania Demographic and Health Survey 2010(9). Birth 100 
outcomes were collected in the third interview, and information on breastfeeding practices in the 101 
fifth. Interviews were conducted by six trained research nurses, who were native Swahili speakers. 102 
The nurses endeavoured to interview the same mothers throughout the study, to create a 103 
consistent and safe environment for them, and were specifically trained in handling sensitive 104 
subjects, such as emotional health and IPV. A small number of participants were involved in pilot-105 
testing of questionnaires. No CROWN initiative core outcome sets (COS) were used in this study, 106 
as no relevant COS currently exist or are under development.  107 
Depression 108 
Information about signs of PPD was collected during the fourth interview, at 40 days postpartum. 109 
A locally translated and pilot-tested Swahili version of the Edinburgh Postnatal Depression Scale 110 
(EPDS)(10, 11) was used, as the EPDS is the most commonly used screening tool for postpartum 111 
depression, in both high- and low-income countries(12, 13), and because it is reliable and cost-112 
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effective(3). The EPDS was translated from English to Swahili by a native speaker. Ten individual 113 
interviews were conducted to assess the quality of the translation and determine whether local 114 
women found the questions meaningful. Based on feedback from the interviewed women, a 115 
revised translation was developed and tested in another round of ten interviews, before being 116 
accepted as the final version used in this study. The EPDS consists of 10 questions, each of which 117 
addresses a clinical symptom of depression. Each question can score from 0-3 with three 118 
representing the most severe option, leading to a maximum score of 30. Based on previous 119 
literature, a cut-off value of 13 was selected to indicate probable postpartum depression(12). 120 
Signs of maternal depression were also collected during pregnancy at 34 weeks gestational age to 121 
assess signs of antenatal depression, and at the final interview 2-3 years after delivery to assess 122 
signs of depression at 2-3 years follow-up, using the same methodology as described above. 123 
Growth 124 
Child growth indicators were assessed in conjunction to the final interview, where anthropometric 125 
measurements were taken of both mother and child. Child growth was expressed through mean 126 
height-for-age z-scores (HAZ), weight-for-age z-scores (WAZ) and weight-for-height z-scores 127 
(WHZ)(14). Z-scores describe how many standard deviations an individual or population is from a 128 
standard population mean. When z-scores are calculated, we take into account height, weight, 129 
age, and sex, meaning that z-scores can be interpreted independently of sex and age(14). The age 130 
of each child was calculated at the final follow-up interview, as time between date of birth and 131 
date of final interview, and height and weight were measured during the same visit. Following 132 
WHO guidelines, children of less than 24 months age had their length measured lying down, and 133 
children ages 24 months or older had their height measured standing(14). A measuring board was 134 
used for the supine measurements, while a stadiometer was used for the standing measurements. 135 
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Weight measurements were performed with an electronic weighing scale. All measurements were 136 
made by trained research nurses. Information on child sex was collected in the 48 hours post-137 
delivery interview. Calculations of z-values were done with the WHO Anthro computer program, 138 
version 3.2.2, using the WHO standard population as the reference population(15). 139 
Statistical analysis 140 
All data was double-entered. Statistical analyses were performed with the Stata software package 141 
(version 15). To determine whether there were any major unexpected differences between the 142 
exposed and unexposed groups, Pearson chi-square and Fischer’s exact test were used as 143 
appropriate, to compare cohort characteristics.  144 
To analyse the association between signs of maternal PPD and each of the three child growth 145 
indicators, linear regression was performed. A theoretical framework, i.e. a directed acyclic graph 146 
(DAG)(16), was developed to assess the potential causal and confounding pathways involved in this 147 
study (figure S1). The DAG network was developed with the DAGitty web-based computer 148 
program, version 2.3(17), and was used a priori to determine which variables to adjust for in the 149 
final regression model. This was done by applying an algorithm within the DAGitty program which 150 
determines the optimal set of potential confounders to adjust for in order to minimize bias in the 151 
regression. The algorithm seeks to identify the smallest possible set of variables that collectively 152 
block all biasing paths in the network. In our network this set consisted of maternal HIV status, 153 
child HIV status, maternal age and maternal exposure to IPV during pregnancy, wherefore these 154 
confounders were chosen to be adjusted for in the final regression model. For practical reasons, a 155 
priori chosen potential confounding variables were removed from the model if the number of 156 
observations was so low that the statistical power suffered, and there was no obvious difference 157 
in observations of the potential confounding variable between the groups. 158 
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The confounders included in the final regression model were assessed for signs of effect 159 
modification. If they showed any such signs, they were included as variables in a stratified analysis, 160 
so the amount and direction of the effect modification could be ascertained. In an effort to assess 161 
how depression at other time points affected the relationship between PPD and child growth, 162 
antenatal depression and depression at 2-3 years follow-up were included in the stratified 163 
analysis. The selection of variables took place a priori.  164 
Ethical considerations 165 
Ethical approval was obtained and all included mothers gave informed consent. The WHO ethical 166 
and safety recommendations for research on domestic violence against women were followed(18). 167 
If the mothers reported IPV, they were offered referrals to relevant institutions. If they showed 168 
signs of PPD, they were offered counselling at local health centres. Severe cases were referred to a 169 
regional hospital where further care, including antidepressant medication (Amitriptyline), was 170 
available. The use of antidepressants is not common in Tanzania and to our knowledge none of 171 
the mothers in this study received medication for their PPD. 172 
This research was funded by the Ministry for Foreign Affairs of Denmark (12-006KU), the A.P. 173 
Møller Foundation (29190909) and the Lundbeck foundation (F-61171-19-27). No funders played 174 
any role in planning or conducting the research, or in writing the paper. 175 
 176 
Results 177 
Figure 1 shows the participant inclusion flowchart. Of the women who attended antenatal care at 178 
the study sites, 1300 were deemed eligible for inclusion and were willing to participate. During the 179 
study period 129 mother-child pairs were excluded as they no longer fulfilled the inclusion criteria, 180 
leaving a true cohort size of 1171 mother-child pairs. The cohort had a follow-up rate of 96.3%. 181 
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The descriptive cohort characteristics for the exposed and the unexposed mothers and children 182 
are shown in table 1. Of the 1128 interviewed mother-child pairs, 12.2% were exposed to 183 
maternal signs of PPD, while 87.8% were not. All mothers reported being either married or in a 184 
relationship at enrolment.  185 
Table 2 shows the crude and adjusted differences in mean for the three growth outcomes HAZ, 186 
WAZ, and WHZ. For the crude regression, only HAZ shows a statistically significant difference 187 
between the PPD exposed and non-exposed groups, with the children in the exposed group being 188 
significantly shorter for their age than the children in the unexposed group (-0.27, 95%CI:-0.43;-189 
0.10). The adjusted regression was controlled for the a priori defined potential confounders 190 
maternal age, maternal HIV status and maternal exposure to IPV during pregnancy. As only 0.4% 191 
of the children were HIV positive, child HIV status was left out of the model due to lack of power. 192 
In the adjusted model the difference remained highly significant for HAZ (-0.32, 95%CI:-0.49;-193 
0.15), while WHZ achieved marginal statistical significance, indicating that the children in the 194 
exposed group were heavier for their height than the children in the unexposed group (0.21, 195 
95%CI:0.02;0.40). 196 
The results of the stratified analyses are presented in table 3. Of the confounders included in the 197 
final regression model, maternal age and exposure to IPV both appeared to be effect modifiers 198 
and were therefore included in the stratified analysis along with antenatal depression and 199 
depression at 2-3 years follow-up. The table shows stratified results for HAZ, WAZ and WHZ, with 200 
maternal exposure to PPD being the main independent variable of interest.  201 
The association between PPD and HAZ retained the same directionality in all subgroups, but to 202 
dissimilar extents. Three of the four stratification variables showed clear effect modification. The 203 
association between PPD and HAZ was stronger among mother-child pairs where mothers were 204 
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exposed to IPV during pregnancy (-0.50, 95%CI:-0.75;-0.25), than among those without IPV 205 
exposure. Similarly, the association was stronger among mothers over the age of 30 (-0.49, 206 
95%CI:-0.81;-0.16) and among those who had depression at 2-3 years follow-up (-0.87, 95%CI:-207 
1.54;-0.20). The fourth stratification variable also suggested effect modification, but not as clearly. 208 
The association between PPD and HAZ was not dramatically different between those with 209 
antenatal depression and those without, yet the statistical significance was only retained in the 210 
group with no antenatal depression (-0.34, 95%CI:-0.54;-0.14). 211 
With regard to PPD and WAZ, only maternal age showed any signs of effect modification, with 212 
significantly decreased WAZ in the oldest subgroup (-0.39, 95%CI:-0.73;-0.05). 213 
There were signs of effect modification for all variables when considering the association between 214 
PPD and WHZ. The association was stronger in the subgroups exposed to IPV (0.37, 215 
95%CI:0.10;0.63) and antenatal depression (0.44, 95%CI:0.05;0.84). Depression at 2-3 years 216 
follow-up also trended towards a stronger association between PPD and WHZ for the exposed 217 
subgroup, but the association was only significant in the unexposed subgroup (0.20, 218 
95%CI:0.01;0.40). Stratifying by maternal age showed a substantial difference in the PPD and WHZ 219 
association, where the children of the younger mothers with PPD were heavier for their height 220 
than those of younger mothers without PPD, while the children of older mothers with PPD were 221 
lighter for their height than their peers. The association however only remained significant for the 222 
mothers aged 20-30 years (0.33, 95%CI:0.10;0.57). 223 
 224 
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Discussion 225 
Main findings 226 
This prospective cohort study shows that maternal exposure to PPD is associated with poorer child 227 
growth outcomes at 2-3 years of age. The children of exposed mothers were found to be 228 
significantly shorter for their age and heavier for their height, compared with their unexposed 229 
peers. The stratified analyses suggested that these relationships were particularly strong among 230 
mothers exposed to IPV during pregnancy, mothers over the age of 30, and mothers with 231 
depressive symptoms at 2-3 years follow-up. The relationship between PPD and HAZ seemed to be 232 
slightly weaker among mothers with signs of antenatal depression. 233 
Somewhat surprisingly, there was no significant difference in exclusive breastfeeding rate 234 
between the PPD and non-PPD groups. This implies that breastfeeding did not play a part in 235 
creating the growth difference in this population. 236 
Strengths and limitations 237 
This study is strengthened by its prospective cohort design. The study population was larger than 238 
any previous cohort studies concerning PPD and child growth in sub-Saharan Africa(2, 7), and the 239 
follow-up rate was >96% after three years. The high follow-up rate was achieved partly by 240 
diligently reminding participants to return for their follow-ups, and partly because the mothers 241 
were appreciative of the services they received in the study. The study population is 242 
representative of the Kilimanjaro region of Tanzania, as can be seen when comparing the cohort 243 
to region specific indicators, such as HAZ -1.1, WAZ -0.4 and WHZ 0.3(19), which correspond to the 244 
mean growth indicators in this study.  245 
The study used the DAG method for confounder choice, which is a method that has gained 246 
momentum within the past ten years. It strengthens the study, as it is a mathematically robust 247 
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way of minimizing bias(16, 17). It is easily reproduced and avoids many problems associated with 248 
traditional methods of bias reduction(16, 17). The main limitation is that the DAG is a simplified 249 
representation of reality(16). While our DAG has been thoroughly researched, it cannot be said to 250 
show the one true causal network. It will change as our knowledge grows and with differing levels 251 
of intricacy included in the network. While we believe our DAG is adequate and that the merits of 252 
this method outweigh the limitations, we acknowledge that the choice of confounders is only as 253 
strong as the DAG.  254 
The use of EPDS to measure maternal depression could be construed as a minor limitation of this 255 
study, as it is a screening tool and cannot diagnose PPD. However, conclusions obtained from 256 
other studies are similar to each other, regardless of whether EPDS or diagnostic interviews are 257 
used. This, combined with the availability and affordability of the EPDS, speaks strongly for its use 258 
as proxy measure for PPD(13). Another limitation is the possible under-reporting of PPD and IPV, as 259 
there is cultural stigma associated with both subjects. We have addressed this problem by training 260 
our interviewers in handling sensitive subjects and conducting interviews privately. If under-261 
reporting took place despite our efforts, this would likely lead to an underestimation of the 262 
association. 263 
Interpretation 264 
The findings in this study are consistent with those of previous research, especially for LICs. A 265 
systematic review of 20 longitudinal studies from low and high income countries found that 266 
children of depressed mothers were more likely to be stunted (HAZ <-2) or underweight (WAZ <-2) 267 
in their first year of life, but that only HAZ continued to be impaired beyond the first year(13). This 268 
supports our finding that HAZ is affected at 2-3 years of age, while WAZ is not. This makes sense, 269 
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as WAZ can be improved at any point with appropriate nutrition, whereas low HAZ reflects the 270 
cumulative effects of chronic malnutrition.  271 
Similarly, a meta-analysis of 17 studies in LICs found that children of mothers with depressive 272 
symptoms were more likely to be underweight or stunted than their peers(8). The studies varied in 273 
design and measured exposure and outcome at different times. This mix of timings could explain 274 
why both HAZ and WAZ are significantly affected in the meta-analysis, while our follow-up at 2-3 275 
years of age only reflects the situation beyond the first year of life.  276 
So far only six other studies have been conducted on the subject of PPD and child growth in sub-277 
Saharan Africa(1,2,6,7,20,21). Collectively, they indicate that maternal PPD negatively impacts HAZ, but 278 
probably not WAZ or WHZ. Thus they support our finding that HAZ was significantly lower in the 279 
exposed group, as well as the null finding for WAZ. Only one of the studies showed results for 280 
WHZ, and these were, in contrast to our study, null(7). Our study shows a slightly increased WHZ 281 
for children of mothers with PPD, but as HAZ, WAZ and WHZ are closely connected, a negatively 282 
different height-for-age and a non-different weight-for-age, must give a positively different 283 
weight-for-height, and this result is therefore not surprising.  284 
The stratified analyses suggest that the association between PPD and child growth is stronger in 285 
some subgroups than in others. The large number of secondary analyses begets a risk of 286 
spuriousness, which must be considered when interpreting the stratified results. Little evidence 287 
exists on the effect modifiers investigated in this paper, but the previously mentioned meta-288 
analysis did find that the worse the depression, the more severe the growth deficit(8). This 289 
supports our finding that while children of mothers with signs of PPD generally have lower HAZ 290 
than their peers, the deficit is larger for those with signs of depression both postpartum and at 2-3 291 
years follow-up. Having depression at both time points could indicate more chronic depression, or 292 
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frequent relapses. Another aspect in support of our finding is that it reached statistical significance 293 
despite the small subgroup size (only 2.4% of the mothers showed signs of depression at 2-3 years 294 
follow-up). 295 
The limited evidence available points towards the association between PPD and child growth 296 
being independent of antenatal depression(13). The association did not differ much between the 297 
antenatal depression subgroups, which indicates independence. However, the association only 298 
reached statistical significance in the subgroup without signs of antenatal depression, which in 299 
turn could imply that the association is with perinatal depression, rather than PPD alone, or it 300 
could simply be due to a loss of statistical power (only 10.2% of the mothers showed signs of 301 
antenatal depression). 302 
No supporting literature was found for IPV exposure and maternal age. While our data suggests 303 
that the association between PPD and poor child growth is stonger among mothers exposed to IPV 304 
during pregnancy and older mothers, these results need verification from further studies. 305 
 306 
Conclusion 307 
This study contributes to the body of evidence indicating that increased focus on maternal mental 308 
health will benefit both maternal and child health. We found that postpartum depressive 309 
symptoms predicted decreased linear height in children at 2-3 years of age, and slightly increased 310 
weight-for-height. This suggests that some growth deficits could be avoided by treating maternal 311 
depressive symptoms. We propose that future research explores this possibility by performing 312 
PPD treatment intervention studies to see if child growth deficits can be avoided, focusing on 313 
culturally appropriate and affordable treatments, to increase their applicability in LICs.  314 
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We suggest that screening for PPD be included in health policies, and that primary care providers 315 
monitor growth more closely for children whose mothers show signs of PPD. 316 
 317 
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Table 1 - Summary of cohort characteristics. 
Characteristics No. of mother-offspring pairs (% of those with characteristic) P-value 
Total - 1128 pairs 
No signs of PPD (EPDS 
<13) - 990 pairs 
Signs of PPD (EPDS ≥13) 
- 138 pairs   
Maternal 
Age at enrolment † 
<20 years 137 (12.1) 125 (12.6) 12 (8.7) 0.053 
20-30 years 740 (65.6) 655 (66.2) 85 (61.6) 
>30 years 251 (22.3) 210 (21.2) 41 (29.7) 
Level of education at enrolment ‡ 
Less than primary 24 (2.1) 20 (2.0) 4 (2.9) 0.041 
Primary 725 (64.3) 623 (62.9) 102 (73.9) 
Secondary 323 (28.6) 295 (29.8) 28 (20.3) 
Above secondary 56 (5.0) 52 (5.3) 4 (2.9) 
Smoking ‡ 
Any smoking during pregnancy 4 (0.4) 2 (0.2) 2 (1.4) 0.076 
Alcohol † 
Any alcohol intake during pregnancy 128 (11.3) 107 (10.8) 21 (15.2) 0.126 
Height at 2-3 years follow-up ‡ 
<150 cm 62 (5.5) 52 (5.3) 10 (7.2) 0.422 
150-170 cm 1041 (92.3) 917 (92.6) 124 (89.9) 
≥170 cm 25 (2.2) 21 (2.1) 4 (2.9) 
Weight at 2-3 years follow-up †        
<55 kg 399 (35.4) 352 (35.6) 47 (34.1) 0.741 
55-65 kg 345 (30.6) 305 (30.8) 40 (29.0)  
≥65 kg 384 (34.0) 333 (33.6) 51 (37.0)  
Parity at baseline † 
0 459 (40.7) 420 (42.4) 39 (28.3) 0.003 
1 335 (29.7) 292 (29.5) 43 (31.2) 
2 213 (18.9) 174 (17.6) 39 (28.3) 
≥3 121 (10.7) 104 (10.5) 17 (12.3) 
HIV status † 
Positive 46 (4.1) 34 (3.4) 12 (8.7) 0.003 
Exposure to IPV during pregnancy † 
Reported any IPV 333 (29.5) 262 (26.5) 71 (51.4) < .001 
Signs of antenatal depression † 
(EPDS ≥13)  115 (10.2) 73 (7.4) 42 (30.4) < .001 
Signs of depression at 2-3 years follow-up † 
(EPDS ≥13) 27 (2.4) 19 (1.9) 8 (5.8) 0.005 
Child 
Sex † 
Female 549 (48.7) 484 (48.9) 65 (47.1) 0.694 
Birth weight † 
<2500g 65 (5.8) 56 (5.7) 9 (6.5) 0.912 
2500-4000g 1011 (89.6) 888 (89.7) 123 (89.1)  
≥4000g 52 (4.6) 46 (4.6) 6 (4.3)  
Preterm birth † 
<37 weeks 65 (5.8) 53 (5.4) 12 (8.7) 0.114 
Child age at 2-3 years follow up ‡ 
<24 months 6 (0.5) 6 (0.6) 0 (0.0) < .001 
24-30 months 658 (58.3) 603 (60.9) 55 (39.9) 
≥30 months 464 (41.1) 381 (38.5) 83 (60.1) 
Confirmed HIV status at 2-3 years follow-up ‡ 
Positive 5 (0.4) 4 (0.4) 1 (0.7) 0.497 
Exclusive breastfeeding † 
≥ 6 months 551 (48.8) 490 (49.5) 61 (44.2) 0.244 
PPD: Postpartum depression, EPDS: Edinburgh postnatal depression scale, BMI: Body mass index, HIV: Human immunodeficiency virus, IPV: Intimate partner 
violence. 
† Difference between groups tested with Pearson's Chi-squared test. 
‡ Difference between groups tested with 2-sided Fisher's exact test. 
 
 Table 2 - Crude and adjusted difference in mean z-scores and 95% CI by exposure to postpartum depression. 
Crude analysis Adjusted analysis  ∤ 
  Mean z-score  (SD) 
Difference in 
mean z-score 95% CI 
Difference in 
mean z-score  95% CI 
Height for age z-score (HAZ) 
No signs of postpartum depression -0.94  (0.94) 
Signs of postpartum depression -1.21  (0.89) -0.27 (-0.43; -0.10) -0.32 (-0.49; -0.15) 
Weight for age z-score (WAZ) 
No signs of postpartum depression -0.34  (0.87) 
Signs of postpartum depression -0.38  (0.86) -0.04 (-0.19; 0.12) -0.04 (-0.20; 0.12) 
Weight for height z-score (WHZ) 
No signs of postpartum depression 0.19  (1.04) 
Signs of postpartum depression 0.37  (0.93) 0.17 (-0.01; 0.35) 0.21 (0.02; 0.40) 
SD: Standard deviation, CI: Confidence interval. 
∤ Adjusted for maternal age, maternal HIV status and maternal exposure to intimate partner violence during pregnancy. 
 
Table 3 - Stratified analysis of maternal exposure to postpartum depression and its association to child z-scores. 
Indicator Height for age z-score Weight for age z-score Weight for height z-score 
  
Difference 
in mean  ∤ 95%CI 
Difference in 
mean  ∤ 95%CI 
Difference in 
mean  ∤ 95%CI 
IPV during pregnancy  ׬  
No  -0.15 (-0.39 ; 0.08) -0.05 (-0.27 ; 0.18) 0.07 (-0.19 ; 0.34) 
Yes -0.50 (-0.75 ; -0.25) -0.03 (-0.25 ; 0.18) 0.37 (0.10  ; 0.63) 
Maternal age  ׭  
<20 years -0.20 (-0.75 ; 0.35) 0.20 (-0.26 ; 0.67) 0.47 (-0.12 ; 1.05) 
20-30 years -0.27 (-0.48 ; -0.05) 0.07 (-0.12 ; 0.27) 0.33 (0.10  ; 0.57) 
>30 years -0.49 (-0.81 ; -0.16)  -0.39 (-0.73 ; -0.05)  -0.15 (-0.53 ; 0.23) 
Antenatal  
depression  ׮    
 
  
 
  
No -0.34 (-0.54 ; -0.14) -0.10 (-0.29 ; 0.08) 0.14 (-0.08 ; 0.36) 
Yes -0.27 (-0.62 ; 0.09) 0.15 (-0.17 ; 0.48) 0.44 (0.05 ; 0.84) 
Depression at 2-3  
years follow-up  ׮        
No -0.30 (-0.48 ; -0.13) -0.04 (-0.20 ; 0.12) 0.20 (0.01 ; 0.40) 
Yes -0.87 (-1.54 ; -0.20) -0.18 (-1.07 ; 0.71) 0.42 (-0.57 ; 1.40) 
CI: Confidence interval. IPV: Intimate partner violence. 
∤  Difference in mean z-score between the group exposed to postpartum depression and the unexposed group, stratified by five indicators of interest. 
׬    Stratified analyses adjusted for maternal age and maternal HIV status. 
׭  Stratified analyses adjusted for maternal HIV status and maternal exposure to intimate partner violence during pregnancy. 
׮ Stratified analyses adjusted for maternal age, maternal HIV status and maternal exposure to intimate partner violence during pregnancy. 
 
